Balanced news tone
News Sentiment
DICOT sentiment intelligence
Dicot Pharma AB news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
93/100 classification confidence.
directly relevant articles
high-authority source matches
-6.0% over one week, -22.9% over four weeks, trend inactive, and below fair value.
Citadel Securities becomes new disclosed short seller in Dicot Pharma
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Citadel Securities becomes new disclosed short seller in Dicot Pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 07:00
- Source
- marketscreener.com
Dicot Pharma recruits Cecilia Driving as new Chief Financial Officer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- TradingView
Dicot Pharma AB Actuals & Estimates (OMXSTO:DICOT)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 17:20
- Source
- TradingView
Dicot Pharma receives FDA clearance for Phase IIb study with LIB-01
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Biostock
Dicot Pharma announces last day of trading in BTU and first day of trading in warrants of series TO 7
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- beQuoted
Dicot Pharma announces final outcome in the oversubscribed rights issue and carries out directed share issues
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- beQuoted
Dicot | Global Forum 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Biostock
The subscription period in Dicot Pharma’s rights issue commences today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- TradingView
Dicot Designs' Mesa Camper Van Sets a New Benchmark for Van Life
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Mar 2026 08:00
- Source
- autoevolution
Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Feb 2026 08:00
- Source
- simplywall.st
Good safety profile for Dicot’s LIB-01
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2025 14:52
- Source
- Biostock
Dicot’s CEO: ”Several prominent people want to be part of the journey”
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2025 02:51
- Source
- Biostock
Dicot’s LIB-01 presented at the SMSNA congress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 May 2025 03:46
- Source
- Biostock
Technical Analysis of Dicot Pharma AB (OMXSTO:DICOT)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Nov 2024 13:18
- Source
- TradingView
Dicot's CEO on preparations for clinic and IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jan 2023 08:00
- Source
- Biostock
The subscription period for warrants of series TO 3 in Dicot begins today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2022 07:00
- Source
- beQuoted
Dicot announces results from study of folk medicine in Madagascar
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jun 2020 07:00
- Source
- Biostock
Dicot develops long-acting Viagra competitor
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Sep 2019 07:00
- Source
- Biostock